Breakthrough £90,000 Alzheimer's drugs unlikely to benefit patients, report suggests

A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.

Več na: https://www.bbc.com/news/articles/cql77wlqlx7o?at_medium=RSS&at_campaign=rss

nazaj